跳至主要内容
临床试验/IRCT201204271556N41
IRCT201204271556N41已完成2 期

ondansetron as adjuvant therapy in the treatment of OCD: a double blind randomized trial

Tehran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Inclusion Criteria: 1-Age between 18-60, 2-Diagnosis of OCD based on DSM IV 3 , Minimum Score of 21 on YALE-BROWN Obsessive-Compulsive Scale

排除标准

  • 1- Substance dependence,2- IQ <70,3-any other mental disorder on axis I, 4-Any serious cardiac, renal or hepatic disease ,5- receiving psychotropic medications during the last 6 weeks 6- pregnancy orbreast feeding 7-rising liver transaminases to three times the upper limit of normal or highe

研究者

相似试验